Molecular Partners appoints Göran Ando as independent non executive board member
Molecular Partners AG announced the appointment of Dr Göran Ando as independent non-executive member of the board of directors.
Dr Ando brings considerable experience to the board of Molecular Partners, having been CEO of Celltech Group, plc. Prior to this, he was Executive Vice President and President R&D for Pharmacia, now Pfizer Inc., where he was also responsible for manufacturing, IT, business development and Mergers & Acquisitions. He has also held positions as R&D Director of Glaxo Group, UK, and was a member of the Glaxo Group Executive Committee. He currently serves as Vice Chairman of the Board of Directors of Novo Nordisk A/S and as Senior Advisor to Essex Woodlands Health Ventures. Dr Ando is a Physician and Specialist in General Medicine and is a Founding Fellow of the American College of Rheumatology in the US.
Organizations
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.